| Firm |
|
Analyst |
BMO Capital Markets
3 Times Square
New York, NY 10036
T. 212-885-4091
www.bmocm.com |
|
Robert Hazlett |
|
Caris & Company
500 Fifth Avenue, Suite 1640
New York, NY 10110
T. 617-728-0712
www.cariscompany.com
|
|
James Molloy |
|
Jefferies & Company, Inc
520 Madison Ave, 10 th floor
New York, NY 10022
T. 212-336-7187
www.jefferies.com/
|
|
Corey Davis |
|
JMP Securities
450 Park Avenue, Suite 1500
New York, NY 10022
T. 312-768-1785
www.jmpsecurities.com
|
|
Liisa A. Bayko |
|
Oppenheimer & Co
300 Madison Ave
New York, NY 10017
T. 212-667-7325
www.opco.com
|
|
John Newman |
|
Piper Jaffray & Co.
150 E. 42nd St., 33rd Floor
New York, NY 10017
T. 212-284-9455
www.piperjaffray.com
|
|
David Amsellem |
|
Roth Capital Partners
24 Corporate Plaza
Newport Beach, CA 92660
T. 949-720-7123
www.roth.com
|
|
Scott Henry |
|
Summer Street Research Partners
One Beacon Street, 34th Floor
Boston MA 02108
T. 617-532-6400
www.ssrp.com/
|
|
Jon Stephenson |
|
Wachovia Securities
375 Park Avenue
New York, NY 10152
T. 212-214-0000
www.wachoviasec.com |
|
Michael K. Tong |
|
Wedbush PacGrow Life Sciences
One Bush Street, Suite 1700
San Francisco, CA 94104
T. 415-263-6646
www.pacificgrowth.com |
|
Patricia L. Bank |
|
Salix Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Salix Pharmaceuticals' performance
made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company or its management. Salix Pharmaceuticals does not by its reference above or distribution
imply its endorsement of or concurrence with such information, conclusions or recommendations.